Otonomy To Challenge Multi-Dose Ear Drops With Otiprio Expansion Plans

Otonomy will file for expanded US approval of Otiprio for use in swimmer’s ear on the back of positive top-line Phase III data – the product has the potential to improve on current treatments in terms of dosing, and the news sent its share price up by more than 10%.